Association of outpatient use of renin-angiotensin-aldosterone system blockers on outcomes of acute respiratory illness during the COVID-19 pandemic: a cohort study.
Molly Moore JefferyLucas Oliveira J E SilvaM Fernanda BellolioVesna D GarovicTimothy M DempseyAndrew LimperNathan W CumminsPublished in: BMJ open (2022)
People with AVRI using ACEi/ARBs for HTN had a greater increase in poor outcomes during the COVID-19 pandemic than those using other medications to treat HTN. The small absolute magnitude of the differences likely does not support changes in clinical practice.